Enhancement of the human factor IX expression, mediated by an intron derived fragment from the rat aldolase B gene in cultured hepatoma cells

Biotechnology Letters

Volumn 32, Issue 10, 2010, Pages 1385-1392

  Sam, Mohammad Reza ^a,b   Zomorodipour, Alireza ^a   Shokrgozar, Mohammad Ali ^c   Ataei, Fariba ^a   Haddad Mashadrizeh, Aliakbar ^d   Amanzadeh, Amir ^c  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b URMIA UNIVERSITY   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Aldolase B intronic enhancer; Cytomegalovirus promoter; Human 1 antitrypsin promoter; Human factor IX; Non viral plasmid

Indexed keywords

ALDOLASES; ANTITRYPSIN; CELL LINES; CIS-ACTING ELEMENT; CODING REGION; CYTOMEGALOVIRUS PROMOTER; EXPRESSION LEVELS; HEPATOCYTES; HEPATOMA CELLS; HUMAN FACTORS; INTRACELLULAR ACCUMULATION; INTRONIC ENHANCER; NONVIRAL; POST-TRANSCRIPTIONAL PROCESS; PROTEIN EXPRESSIONS; SECOND GENERATION;

CELL CULTURE; ENZYME ACTIVITY; HUMAN ENGINEERING; MICROBIOLOGY; PROTEINS; TUMORS;

GENE EXPRESSION;

ALPHA 1 ANTITRYPSIN; BLOOD CLOTTING FACTOR 9; FRUCTOSE BISPHOSPHATE ALDOLASE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BIOTECHNOLOGY; CELL LINE; CYTOMEGALOVIRUS; GENE EXPRESSION; GENETICS; HUMAN; INTRON; LIVER CELL; METABOLISM; METHODOLOGY; PLASMID; PROMOTER REGION; RAT;

ALPHA 1-ANTITRYPSIN; ANIMALS; BIOTECHNOLOGY; CELL LINE; CYTOMEGALOVIRUS; FACTOR IX; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION; HEPATOCYTES; HUMANS; INTRONS; PLASMIDS; PROMOTER REGIONS, GENETIC; RATS; RECOMBINANT PROTEINS;

CYTOMEGALOVIRUS; RATTUS;

EID: 77956742932     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-010-0321-x     Document Type: Article

References (24)

1. Armentano D, Thompson AR, Darlington G, Woo SL (1990) Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci USA 87: 6141-6145.
2. Berkner KL (1993) Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII. Methods Enzymol 222: 450-477.
3. Dai Y, Roman M, Naviaux RK, Verma IM (1992) Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 89: 10892-10895.
4. Fair DS, Bahnak BR (1984) Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood 64: 194-204.
5. Furger A, O'Sullivan JM, Binnie A, Lee BA, Proudfoot NJ (2002) Promoter proximal splice sites enhance transcription. Genes Dev 16: 2792-2799.
6. Gregori C, Porteu A, Lopez S, Kahn A, Pichard AL (1998) Characterization of the aldolase B intronic enhancer. J Biol Chem 273: 25237-25243.
7. Haddad-Mashadrizeh A, Zomorodipour A, Izadpanah M, Sam MR, Ataei F, Sabouni F, Hosseini SJ (2009) A systematic study of the function of the human beta-globin introns on the expression of the human coagulation factor IX in cultured Chinese hamster ovary cells. J Gene Med 11: 941-950.
8. Hagstrom JN, Couto LB, Scallan C, Burton M, McCleland ML, Fields PA, Arruda VR, Herzog RW, High KA (2000) Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood 95: 2536-2542.
9. Harding TC, Koprivnikar KE, Tu GH, Zayek N, Lew S, Subramanian A, Sivakumaran A, Frey D, Ho K, VanRoey MJ, Nichols TC, Bellinger DA, Yendluri S, Waugh J, McArthur J, Veres G, Donahue BA (2004) Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene Ther 11: 204-213.
10. High KA (2000) Clinical gene transfer studies for hemophilia B. Semin Thromb Hemost 30: 257-267.
11. Kay MA, Manno CS, Ragni MV et al (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 24: 257-261.
12. Kramer MG, Barajas M, Razquin N, Berraondo P, Rodrigo M, Wu C, Qian C, Fortes P, Prieto J (2003) In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther 7: 375-385.
13. Kurachi S, Hitomi Y, Furukawa M, Kurachi K (1995) Role of intron I in expression of the human factor IX gene. J Biol Chem 270: 5276-5281.
14. Le Hir H, Nott A, Moore MJ (2003) How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28: 215-220.
15. Majewski J, Ott J (2002) Distribution and characterization of regulatory elements in the human genome. Genome Res 12: 1827-1836.
16. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL (1991) Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci USA 88: 478-482.
17. Plantier JL, Rodriguez MH, Enjolras N, Attali O, Négrier C (2001) A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII. Thromb Haemost 86: 596-603.
18. Rodriguez MH, Enjolras N, Plantier JL, Réa M, Leboeuf M, Uzan G, Bordet JC, Négrier C (2002) Expression of coagulation factor IX in a haematopoietic cell line. Thromb Haemost 87: 366-373.
19. Roth DA, Kessler CM, Pasi KJ, Rup B, Courter SG, Tubridy KL (2001) Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates. Blood 98: 3600-3606.
20. Sabourin JC, Kern AS, Grégori C, Porteu A, Cywiner C, Châtelet FP, Kahn A, Pichard AL (1996) An intronic enhancer essential for tissue-specific expression of the aldolase B transgenes. J Biol Chem 271: 3469-3473.
21. Sambrook RD (2001) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, New York, NY.
22. Sifers RN, Carlson JA, Clift SM, DeMayo FJ, Bullock DW, Woo SL (1987) Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res 15: 1459-1475.
23. Tagliavacca L, Wang Q, Kaufman RJ (2000) ATP-dependent dissociation of non-disulfide-linked aggregates of coagulation factor VIII is a rate-limiting step for secretion. Biochemistry 39: 1973-1981.
24. Wajih N, Hutson SM, Wallin R (2006) siRNA silencing of calumenin enhances functional factor IX production. Blood 108: 3757-3760.